224 related articles for article (PubMed ID: 2209315)
21. Effects of omega-3 and omega-6 fatty acid-rich oils on the cardiovascular system of thermally injured rabbits: changes in plasma triglycerides, plasma cholesterol, relative blood viscosity, platelet count, and bleeding time.
Kirmani ZA; Baxter CR; Gorman MA; Ashby J; Ireton-Jones C; Liepa GU
J Burn Care Rehabil; 1995; 16(3 Pt 1):306-15. PubMed ID: 7673312
[TBL] [Abstract][Full Text] [Related]
22. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
[TBL] [Abstract][Full Text] [Related]
23. Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years.
Saynor R; Gillott T
Lipids; 1992 Jul; 27(7):533-8. PubMed ID: 1453884
[TBL] [Abstract][Full Text] [Related]
24. Indomethacin inhibits the effects of dietary supplementation with marine oils on vasoconstriction of human forearm resistance vessels in vivo.
Chin JP; Gust AP; Dart AM
J Hypertens; 1993 Nov; 11(11):1229-34. PubMed ID: 8301104
[TBL] [Abstract][Full Text] [Related]
25. A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM.
Morgan WA; Raskin P; Rosenstock J
Diabetes Care; 1995 Jan; 18(1):83-6. PubMed ID: 7698053
[TBL] [Abstract][Full Text] [Related]
26. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
[TBL] [Abstract][Full Text] [Related]
27. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males.
Cobiac L; Clifton PM; Abbey M; Belling GB; Nestel PJ
Am J Clin Nutr; 1991 May; 53(5):1210-6. PubMed ID: 1826986
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes.
McManus RM; Jumpson J; Finegood DT; Clandinin MT; Ryan EA
Diabetes Care; 1996 May; 19(5):463-7. PubMed ID: 8732710
[TBL] [Abstract][Full Text] [Related]
29. Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients.
Pirich C; Gaszo A; Granegger S; Sinzinger H
Thromb Res; 1999 Nov; 96(3):219-27. PubMed ID: 10588465
[TBL] [Abstract][Full Text] [Related]
30. Triglyceride lowering effect of MaxEPA fish lipid concentrate: a multicentre placebo controlled double blind study.
Miller JP; Heath ID; Choraria SK; Shephard NW; Gajendragadkar RV; Harcus AW; Batson GA; Smith DW; Saynor R
Clin Chim Acta; 1988 Dec; 178(3):251-9. PubMed ID: 3071435
[TBL] [Abstract][Full Text] [Related]
31. Effect of MaxEPA (fish oil) on lipoproteins and its receptors in hypercholesterolemic rabbits.
Achtani C; Awtade A; Vasisht S; Srivastava LM
Biochem Mol Biol Int; 1995 Oct; 37(3):489-98. PubMed ID: 8595389
[TBL] [Abstract][Full Text] [Related]
32. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.
Zulyniak MA; Perreault M; Gerling C; Spriet LL; Mutch DM
Metabolism; 2013 Aug; 62(8):1107-13. PubMed ID: 23522836
[TBL] [Abstract][Full Text] [Related]
33. Effects of supplemented omega-3 and omega-6 fatty acid rich oils on the cardiovascular system of thermally injured rabbits: changes in plasma and platelet fatty acids.
Kirmani ZA; Baxter CR; Gorman MA; Ashby J; Ireton-Jones C; Liepa GU
J Burn Care Rehabil; 1995; 16(2 Pt 1):173-9; discussion 172. PubMed ID: 7775514
[TBL] [Abstract][Full Text] [Related]
34. Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients.
Rylance PB; Gordge MP; Saynor R; Parsons V; Weston MJ
Nephron; 1986; 43(3):196-202. PubMed ID: 3724927
[TBL] [Abstract][Full Text] [Related]
35. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus.
Vessby B; Boberg M
J Intern Med; 1990 Aug; 228(2):165-71. PubMed ID: 2394967
[TBL] [Abstract][Full Text] [Related]
36. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
Barbosa MM; Melo AL; Damasceno NR
Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
[TBL] [Abstract][Full Text] [Related]
37. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
38. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.
Hammes HP; Weiss A; Führer D; Krämer HJ; Papavassilis C; Grimminger F
Diabetologia; 1996 Mar; 39(3):251-5. PubMed ID: 8721768
[TBL] [Abstract][Full Text] [Related]
39. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease.
Mori TA; Beilin LJ; Burke V; Morris J; Ritchie J
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):279-86. PubMed ID: 9081682
[TBL] [Abstract][Full Text] [Related]
40. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
Mori TA; Burke V; Puddey IB; Watts GF; O'Neal DN; Best JD; Beilin LJ
Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
